FDA.reportPublic FDA data

fondaparinux sodium 5 MG per 0.4 ML Prefilled Syringe

RxCUI
861363
RxNorm name
fondaparinux sodium 5 MG per 0.4 ML Prefilled Syringe
Display name
fondaparinux sodium 5 MG per 0.4 ML Prefilled Syringe
Full name
fondaparinux sodium 5 MG per 0.4 ML Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 7 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
fondaparinux sodiumFONDAPARINUX SODIUMZydus Pharmaceuticals (USA) Inc.dffbf7c9-495e-4a33-ac76-57b52f014fc22025-10-28Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 861363
Fondaparinux SodiumFONDAPARINUX SODIUMSandoz Inc.baa50757-a927-4d56-a933-5d7798fe6ab02025-08-27Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 861363
ArixtraFONDAPARINUX SODIUMMylan Institutional LLCd3b30c68-cf45-4b46-8ba6-72090f7ba01a2024-12-10Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 861363
FONDAPARINUX SODIUMFONDAPARINUX SODIUMEugia US LLC8ea61d0d-4403-4d9f-a946-85a459cc0aa02024-01-10Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 861363
Fondaparinux SodiumFONDAPARINUX SODIUMDr. Reddy's Laboratories Limited49e0d7bc-3f49-849b-c77c-98682d1c0d192021-09-10Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 861363
fondaparinux sodiumFONDAPARINUX SODIUMItalfarmaco S.p.A58789e3d-e5bc-4c2e-a527-495a252fcecd2020-10-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 861363
Fondaparinux SodiumFONDAPARINUX SODIUMMylan Institutional LLC4b65f642-87f7-4da5-a9c9-02cd1f8d9d162020-08-15Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 861363

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 8 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
dffbf7c9-495e-4a33-ac76-57b52f014fc2fondaparinux sodium 5 MG in 0.4 ML Prefilled Syringe [PSN] · 0.4 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe [SCD] · fondaparinux sodium 5 MG per 0.4 ML Prefilled Syringe [SY]320These highlights do not include all the information needed to use FONDAPARINUX SODIUM INJECTION safely and effectively. See full prescribing information for FONDAPARINUX SODIUM INJECTION. FONDAPARINUX SODIUM injection, for subcutaneous use Initial U.S. Approval: 200120251028
baa50757-a927-4d56-a933-5d7798fe6ab0fondaparinux sodium 5 MG in 0.4 ML Prefilled Syringe [PSN] · 0.4 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe [SCD] · fondaparinux sodium 5 MG per 0.4 ML Prefilled Syringe [SY]318These highlights do not include all the information needed to use FONDAPARINUX SODIUM INJECTION safely and effectively. See full prescribing information for FONDAPARINUX SODIUM INJECTION. FONDAPARINUX SODIUM injection, for subcutaneous use Initial U.S. Approval: 200120250827
49e0d7bc-3f49-849b-c77c-98682d1c0d19fondaparinux sodium 5 MG in 0.4 ML Prefilled Syringe [PSN] · 0.4 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe [SCD] · fondaparinux sodium 5 MG per 0.4 ML Prefilled Syringe [SY]316These highlights do not include all the information needed to use FONDAPARINUX SODIUM INJECTION safely and effectively. See full prescribing information for FONDAPARINUX SODIUM INJECTION. FONDAPARINUX SODIUM injection for subcutaneous use Initial U.S. Approval: 200120210910
d3b30c68-cf45-4b46-8ba6-72090f7ba01afondaparinux sodium 5 MG in 0.4 ML Prefilled Syringe [PSN] · 0.4 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe [SCD] · fondaparinux sodium 5 MG per 0.4 ML Prefilled Syringe [SY]313These highlights do not include all the information needed to use ARIXTRA safely and effectively. See full prescribing information for ARIXTRA. ARIXTRA (fondaparinux sodium injection), for subcutaneous use Initial U.S. Approval: 200120241210
58789e3d-e5bc-4c2e-a527-495a252fcecdfondaparinux sodium 5 MG in 0.4 ML Prefilled Syringe [PSN] · 0.4 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe [SCD] · fondaparinux sodium 5 MG per 0.4 ML Prefilled Syringe [SY]311These highlights do not include all the information needed to use FONDAPARINUX SODIUM INJECTION safely and effectively. See full prescribing information for FONDAPARINUX SODIUM INJECTION. FONDAPARINUX SODIUM injection, for subcutaneous use Initial U.S. Approval: 200120201030
4b65f642-87f7-4da5-a9c9-02cd1f8d9d16fondaparinux sodium 5 MG in 0.4 ML Prefilled Syringe [PSN] · 0.4 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe [SCD] · fondaparinux sodium 5 MG per 0.4 ML Prefilled Syringe [SY]311These highlights do not include all the information needed to use FONDAPARINUX SODIUM INJECTION safely and effectively. See full prescribing information for FONDAPARINUX SODIUM INJECTION. FONDAPARINUX SODIUM injection, for subcutaneous use Initial U.S. Approval: 200120200815
8ea61d0d-4403-4d9f-a946-85a459cc0aa0fondaparinux sodium 5 MG in 0.4 ML Prefilled Syringe [PSN] · 0.4 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe [SCD] · fondaparinux sodium 5 MG per 0.4 ML Prefilled Syringe [SY]35These highlights do not include all the information needed to use FONDAPARINUX SODIUM INJECTION safely and effectively. See full prescribing information for FONDAPARINUX SODIUM INJECTION. FONDAPARINUX SODIUM injection, for subcutaneous use Initial U.S. Approval: 200120240110
ec235119-cb58-4939-942c-11d3923d289ffondaparinux sodium 5 MG in 0.4 ML Prefilled Syringe [PSN] · 0.4 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe [SCD] · fondaparinux sodium 5 MG per 0.4 ML Prefilled Syringe [SY]31These highlights do not include all the information needed to use ARIXTRA safely and effectively. See full prescribing information for ARIXTRA. ARIXTRA (fondaparinux sodium) Solution for subcutaneous injection Initial U.S. Approval: 200120120123